EUVIMED · CrossrefZeitschrift
ESMO Real World Data and Digital Oncology
ISSN 2949-8201 · Elsevier BV
Neueste Artikel
Racial disparities in cancer burden, care pathways, and mortality among women in Brazil: a nationwide real-world analysis
Development of an algorithm to support cancer registry registration by identifying patients with metachronous metastases after primary breast cancer
Advancing population-based cancer registries through the OHDSI OMOP Common Data Model: governance, validation, and interoperability for cancer research
Abemaciclib plus endocrine therapy in high-risk, node-positive early breast cancer in Italian practice: interim analysis of prospective observational IT-PATH study
Real-world characteristics, testing patterns, and outcomes in patients with tropomyosin receptor kinase fusion cancer from a large pooled clinicogenomic database
Review on FRench Evidence-based National Chemotherapy Treatment decision in early breast cancer using multigene assays: FRENCH-Touch project
Reply to “Beyond pairwise comparisons of androgen receptor signaling inhibitors in nonmetastatic castration-resistant prostate cancer”
Implementation of the Toronto guidelines for childhood cancer staging: experience from 65 population-based cancer registries participating in the BENCHISTA project
1O Protein language model-enabled circulating TCRβ repertoire multiple-instance learning for early NSCLC detection
2RO Complementary diagnostic information from DNAm and RNA-seq highlights the need for multimodal sarcoma classification
3P A pan-cancer foundation-model atlas of regulatory variant function and its prognostic application across 238,000 tumors
4P AI-assisted pan-cancer prognostic stratification of GREM1 reveals a context-dependent cancer risk signature
5P Deconvolving bulk tumor transcriptomes: A pan-cancer deep learning approach
6P Unsupervised transcriptomic topic modelling identifies histologically aligned expression topics in thymic epithelial tumors
7P Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
8P Effects of cross-validation design on reported biomarker performance in small clinical cohorts
9P A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
10P Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
11P Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
12P A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
13P Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
14P A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
15P Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
16P GenieFormer: a cfDNA methylation-based large language model (LLM) for early-stage lung cancer detection
17P Benchmarking DNA methylation large language models (LLMs) for cell-free DNA (cfDNA)-based pancreatic cancer detection
18P Toward liquid-biopsy-driven precision oncology: cross-cohort machine learning on plasma methylation and ctDNA fraction in breast and colorectal cancer
19P Modelling lung nodule evolution for malignancy prediction
20P Tissue language model: A novel class of self-supervised pathology slide foundation model
21P Foundation models provide reliable features to microenvironment analysis in digital pathology
22P Mapping histology-defined spatial heterogeneity for interpretable biomarker discovery across tumor types
EUVIMED